Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

Introduction: O(6)-methylguanine-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase (IDH) mutation status are important prognostic factors for patients with glioblastoma. There are conflicting reports about a differential topographical distribution of glioblastoma with vs. wi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Autores principales: Incekara, Fatih, van der Voort, Sebastian R., Dubbink, Hendrikus J., Atmodimedjo, Peggy N., Nandoe Tewarie, Rishi, Lycklama, Geert, Vincent, Arnaud J. P. E., Kros, Johan M., Klein, Stefan, van den Bent, Martin, Smits, Marion
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7235346/
https://ncbi.nlm.nih.gov/pubmed/32477929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00596
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares